Okamoto A

No ORCID on file · 30 papers in corpus
article 2015
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.12811

AIM: To evaluate the efficacy and adverse effects of Dienogest (DNG) over 53 weeks for the treatment of endometriosis. METHODS: DNG was administered to 75 patients with endometriosis over a period of 53 weeks. Medical charts were retrospect…

other 2014
BMC cancer ·doi:10.1186/1471-2407-14-799

BACKGROUND: Epithelial ovarian cancer (EOC) is the most common cause of gynecological malignancy-related mortality. Ovarian clear cell carcinoma (CCC) has unique clinical characteristics and behaviors that differ from other histological typ…

article 2013
Hinyokika kiyo. Acta urologica Japonica

A 40-year-old woman visited our hospital with asymptomatic macroscopic hematuria. A nonpapillary ureteral tumor protruding from the left orifice was identified by cystoscopy. Computed tomography revealed left hydronephrosis due to the urete…

article 2012
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.2011.01778.x

AIM: Adenomyosis patients treated with dienogest are considered to be at higher risk of uterine bleeding; however, the mechanisms which cause severe uterine bleeding in those patients are unknown. This study aims to investigate the risk fac…

article 2007
Oncology reports ·doi:10.3892/or.17.6.1333

We previously reported that indoleamine-2,3-dioxygenase (IDO) is associated with paclitaxel resistance and that IDO serves as a marker of poor prognosis in ovarian serous adenocarcinomas (SA). In this study, to explore the role of IDO in th…